Logo image of CO.PA

CASINO GUICHARD PERRACHON (CO.PA) Stock Fundamental Analysis

EPA:CO - Euronext Paris - Matif - FR001400OKR3 - Common Stock - Currency: EUR

0.936  -0.02 (-2.18%)

Fundamental Rating

2

Taking everything into account, CO scores 2 out of 10 in our fundamental rating. CO was compared to 27 industry peers in the Consumer Staples Distribution & Retail industry. CO has a bad profitability rating. Also its financial health evaluation is rather negative. CO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CO had negative earnings in the past year.
In the past year CO has reported a negative cash flow from operations.
In the past 5 years CO always reported negative net income.
CO had a positive operating cash flow in 4 of the past 5 years.
CO.PA Yearly Net Income VS EBIT VS OCF VS FCFCO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B -4B

1.2 Ratios

Looking at the Return On Assets, with a value of -55.72%, CO is doing worse than 96.15% of the companies in the same industry.
Looking at the Return On Equity, with a value of -363.88%, CO is doing worse than 96.15% of the companies in the same industry.
Industry RankSector Rank
ROA -55.72%
ROE -363.88%
ROIC N/A
ROA(3y)-11.2%
ROA(5y)-8.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CO.PA Yearly ROA, ROE, ROICCO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

The Gross Margin of CO (28.15%) is better than 76.92% of its industry peers.
In the last couple of years the Gross Margin of CO has grown nicely.
The Profit Margin and Operating Margin are not available for CO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.15%
GM growth 5Y2.07%
CO.PA Yearly Profit, Operating, Gross MarginsCO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

2

2. Health

2.1 Basic Checks

CO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CO has been reduced compared to 1 year ago.
CO has less shares outstanding than it did 5 years ago.
CO has a worse debt/assets ratio than last year.
CO.PA Yearly Shares OutstandingCO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CO.PA Yearly Total Debt VS Total AssetsCO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

CO has an Altman-Z score of -0.24. This is a bad value and indicates that CO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.24, CO is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
CO has a Debt/Equity ratio of 2.10. This is a high value indicating a heavy dependency on external financing.
CO has a worse Debt to Equity ratio (2.10) than 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Altman-Z -0.24
ROIC/WACCN/A
WACC2.98%
CO.PA Yearly LT Debt VS Equity VS FCFCO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.93 indicates that CO may have some problems paying its short term obligations.
The Current ratio of CO (0.93) is comparable to the rest of the industry.
A Quick Ratio of 0.76 indicates that CO may have some problems paying its short term obligations.
CO has a better Quick ratio (0.76) than 80.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.76
CO.PA Yearly Current Assets VS Current LiabilitesCO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

1

3. Growth

3.1 Past

The earnings per share for CO have decreased strongly by -147.51% in the last year.
CO shows a decrease in Revenue. In the last year, the revenue decreased by -6.20%.
The Revenue for CO have been decreasing by -23.64% on average. This is quite bad
EPS 1Y (TTM)-147.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.01%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-34.7%
Revenue growth 5Y-23.64%
Sales Q2Q%-6.1%

3.2 Future

Based on estimates for the next years, CO will show a very strong growth in Earnings Per Share. The EPS will grow by 25.97% on average per year.
Based on estimates for the next years, CO will show a very negative growth in Revenue. The Revenue will decrease by -32.99% on average per year.
EPS Next Y101.13%
EPS Next 2Y41.28%
EPS Next 3Y25.97%
EPS Next 5YN/A
Revenue Next Year-70.09%
Revenue Next 2Y-45.35%
Revenue Next 3Y-32.99%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CO.PA Yearly Revenue VS EstimatesCO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B 50B
CO.PA Yearly EPS VS EstimatesCO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 200 -200 400

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CO.PA Price Earnings VS Forward Price EarningsCO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CO.PA Per share dataCO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K -4K -5K

4.3 Compensation for Growth

A more expensive valuation may be justified as CO's earnings are expected to grow with 25.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.28%
EPS Next 3Y25.97%

0

5. Dividend

5.1 Amount

CO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CASINO GUICHARD PERRACHON

EPA:CO (2/5/2025, 9:22:34 AM)

0.936

-0.02 (-2.18%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst Owners8.06%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap375.28M
Analysts36.36
Price Target2.12 (126.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-64.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-53.88%
EPS NY rev (3m)-53.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-51%
Revenue NY rev (3m)-51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5237.14
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS33.1
BVpS3.85
TBVpS-2.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.72%
ROE -363.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.15%
FCFM N/A
ROA(3y)-11.2%
ROA(5y)-8.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.15%
GM growth 5Y2.07%
F-Score3
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.52%
Cap/Sales 0.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.76
Altman-Z -0.24
F-Score3
WACC2.98%
ROIC/WACCN/A
Cap/Depr(3y)86.16%
Cap/Depr(5y)82.23%
Cap/Sales(3y)8.21%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.01%
EPS Next Y101.13%
EPS Next 2Y41.28%
EPS Next 3Y25.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-34.7%
Revenue growth 5Y-23.64%
Sales Q2Q%-6.1%
Revenue Next Year-70.09%
Revenue Next 2Y-45.35%
Revenue Next 3Y-32.99%
Revenue Next 5YN/A
EBIT growth 1Y-284.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year958.88%
EBIT Next 3Y214.91%
EBIT Next 5YN/A
FCF growth 1Y-45200%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-122.78%
OCF growth 3YN/A
OCF growth 5YN/A